Paper42301302
Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial.
Kawazoe M and 14 others. Osteoporos Int, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial. Papers, record 42301302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42301302
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucocorticoids | Major topic |
| Denosumab | Major topic |
| Bone Density Conservation Agents | Major topic |
| Osteoporosis | Major topic |
| Antibodies, Monoclonal | Major topic |
| Humans | |
| Female | |
| Aged | |
| Male | |
| Bone Density | |
| Drug Administration Schedule | |
| Drug Therapy, Combination | |
| Middle Aged | |
| Prednisolone | |
| Treatment Outcome | |
| Rheumatic Diseases | |
| Lumbar Vertebrae | |
| Bridge Therapy | |
| Risedronic Acid | |
| Femur Neck | |
| Diphosphonates |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JP 21K16665 | JSPS KAKENHI | PubMed | ||
| No.19-19 | Project Research Grant from Toho University School of Medicine | PubMed |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25385412 | Glucocorticoid-induced osteoporosis: who to treat with what agent? | Nat Rev Rheumatol | 2015 | https://conductscience.org/library/papers/25385412 | PubMed |
| 2 | 12378366 | The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. | Osteoporos Int | 2002 | https://conductscience.org/library/papers/12378366 | PubMed |
| 3 | 24818875 | Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update. | J Bone Miner Metab | 2014 | https://conductscience.org/library/papers/24818875 | PubMed |
| 4 | 3165380 | Structure of the human liver/bone/kidney alkaline phosphatase gene. | J Biol Chem | 1988 | https://conductscience.org/library/papers/3165380 | PubMed |
| 5 | 31513250 | Efficacy and Safety of First- and Second-Line Drugs to Prevent Glucocorticoid-Induced Fractures. | J Clin Endocrinol Metab | 2020 | https://conductscience.org/library/papers/31513250 | PubMed |
| 6 | 38267664 | Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan. | Osteoporos Int | 2024 | https://conductscience.org/library/papers/38267664 | PubMed |
| 7 | 39387335 | Romosozumab versus denosumab in long-term users of glucocorticoids: A pilot randomized controlled trial. | J Intern Med | 2024 | https://conductscience.org/library/papers/39387335 | PubMed |
| 8 | 31214839 | The association of urinary pentosidine levels with the prevalence of osteoporotic fractures in postmenopausal women. | J Bone Miner Metab | 2019 | https://conductscience.org/library/papers/31214839 | PubMed |
| 9 | 21362762 | Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. | J Rheumatol | 2011 | https://conductscience.org/library/papers/21362762 | PubMed |
| 10 | 23788684 | Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. | J Clin Endocrinol Metab | 2013 | https://conductscience.org/library/papers/23788684 | PubMed |
| 11 | 18470669 | Short-term effects of glucocorticoid therapy on biochemical markers of bone metabolism in Japanese patients: a prospective study. | J Bone Miner Metab | 2008 | https://conductscience.org/library/papers/18470669 | PubMed |
| 12 | 39530312 | Pilot study of the effect of surgical menopause on bone mineral density and quality in patients with gynecological malignancies. | J Obstet Gynaecol Res | 2025 | https://conductscience.org/library/papers/39530312 | PubMed |
| 13 | 10841167 | Use of oral corticosteroids and risk of fractures. | J Bone Miner Res | 2000 | https://conductscience.org/library/papers/10841167 | PubMed |
| 14 | 26694595 | Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials. | Osteoporos Int | 2016 | https://conductscience.org/library/papers/26694595 | PubMed |
| 15 | 16937274 | Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen. | J Bone Miner Metab | 2006 | https://conductscience.org/library/papers/16937274 | PubMed |
| 16 | 17566815 | Glucocorticoid-induced osteoporosis: pathophysiology and therapy. | Osteoporos Int | 2007 | https://conductscience.org/library/papers/17566815 | PubMed |
| 17 | 12730746 | A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group). | Osteoporos Int | 2003 | https://conductscience.org/library/papers/12730746 | PubMed |
| 18 | 27273113 | Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. | Osteoporos Int | 2016 | https://conductscience.org/library/papers/27273113 | PubMed |
| 19 | 27641143 | Romosozumab Treatment in Postmenopausal Women with Osteoporosis. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27641143 | PubMed |
| 20 | 28551822 | Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases. | Clin Rheumatol | 2018 | https://conductscience.org/library/papers/28551822 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42761068 | Case Report: Reopening the anabolic window - romosozumab added to ongoing denosumab for severe osteoporosis in two kidney transplant recipients. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42761068 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACP5 | 54 | PubTator's text mining | https://conductscience.org/library/genes/54 | NCBI Gene |
| SOST | 50964 | PubTator's text mining | https://conductscience.org/library/genes/50964 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42301302
GET https://conductscience.org/api/papers/v1/42301302/references?page=2